AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma.

Background: Locoregional recurrence of nasopharyngeal carcinoma (NPC) occurs in 10% to 50% of cases following primary treatment. However, the current main prognostic markers for NPC, both stage and plasma Epstein-Barr virus DNA, are not sensitive to locoregional recurrence.

Methods: We gathered 385 whole-slide images (WSIs) from haematoxylin and eosin (H&E)-stained NPC sections ( = 367 cases), which were collected from Sun Yat-sen University Cancer Centre. We developed a deep learning algorithm to detect tumour nuclei and lymphocyte nuclei in WSIs, followed by density-based clustering to quantify the tumour-infiltrating lymphocytes (TILs) into 12 scores. The Random Survival Forest model was then trained on the TILs to generate risk score.

Results: Based on Kaplan-Meier analysis, the proposed methods were able to stratify low- and high-risk NPC cases in a validation set of locoregional recurrence with a statically significant result ( < 0.001). This finding was also found in distant metastasis-free survival ( < 0.001), progression-free survival ( < 0.001), and regional recurrence-free survival ( < 0.05). Furthermore, in both univariate analysis (HR: 1.58, CI: 1.13-2.19, < 0.05) and multivariate analysis (HR:1.59, CI: 1.11-2.28, < 0.05), we also found that our methods demonstrated a strong prognostic value for locoregional recurrence.

Conclusion: The proposed novel digital markers could potentially be utilised to assist treatment decisions in cases of NPC.